Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Thomas

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Leukemia|January 26, 2007
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) GroupX Thomas, E Raffoux, S de Botton, et al.
Leukemia|January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 casesR Itzykson, S Ayari, D Vassilief, et al.
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.
Developmental Cell|November 19, 2019
Mutations in ANKLE2, a ZIKA Virus Target, Disrupt an Asymmetric Cell Division Pathway in Drosophila Neuroblasts to Cause MicrocephalyNichole Link, Hyunglok Chung, Angad Jolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia groupS de Botton, A Fawaz, S Chevret, et al.
Leukemia|November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceL Ades, S Chevret, S De Botton, et al.
Blood Cancer Journal|December 10, 2016
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL studyA Desjonquères, P Chevallier, X Thomas, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Leukemia|January 26, 2007
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) GroupX Thomas, E Raffoux, S de Botton, et al.
Leukemia|January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 casesR Itzykson, S Ayari, D Vassilief, et al.
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.
Developmental Cell|November 19, 2019
Mutations in ANKLE2, a ZIKA Virus Target, Disrupt an Asymmetric Cell Division Pathway in Drosophila Neuroblasts to Cause MicrocephalyNichole Link, Hyunglok Chung, Angad Jolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia groupS de Botton, A Fawaz, S Chevret, et al.
Leukemia|November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceL Ades, S Chevret, S De Botton, et al.
Blood Cancer Journal|December 10, 2016
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL studyA Desjonquères, P Chevallier, X Thomas, et al.
Pageof 20